JPRN-UMIN000018939
Completed
未知
Analysis of drug distributions in tissue section using mass imaging technology in patients with breast cancer - Analysis of drug distributions in tissue section using mass imaging technology in patients with breast cancer
Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital0 sites20 target enrollmentSeptember 8, 2015
Conditionsbreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •a. Patients with active infection b. Patients with other serious disease c. Patients with coagulation abnormalities or patients who are not possible to rest anticoagulants d. Patients with history of severe drug allergy e. Pregnant or nursing females f. Patients whose participation in the study is judged to be inappropriate by the attending doctor.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The examination of concentration of drug in tissues from the knee osteoarthritis patients who use the Esflurbiprofen tape or FlurbiprofeosteoarthritisJPRN-UMIN000024789Tokyo Medical and Dental University14
Suspended
Not Applicable
analysis of antibiotics concentration in tissuetonsilitis, sinusitis, otitis mediaJPRN-UMIN000028704Keio University54
Active, not recruiting
Not Applicable
Pharmakokinetic investigation on the tissue penetration of moxifloxacin within the pericardial spacePatients with chronic pericardial effusion , 5 of them with pericardial effusion indiced by malignancies, 10 of them with chronic inflammatory pericardial effusionMedDRA version: 9.1Level: PTClassification code 10034474Term: Pericardial effusionEUCTR2007-006051-39-DEPhilipps Universität Marburg15
Completed
Phase 1
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study)Cervical epidermoid carcinoma, stage IB2-II.RPCEC00000142Center for Genetic Engineering and Biotechnology (CIGB)
Active, not recruiting
Not Applicable
Certain tumor bearings views using [18F]FMISO, INJ SOL in patiens with cancer disease.Patients with sguamous cell carcinomasMedDRA version: 14.1Level: PTClassification code 10041823Term: Squamous cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-000839-84-CZRadioMedic s.r.o.